Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 3/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.32 |
| ▸ | RAB9A | P51151 | 2/20 | 0.31 |
| ▸ | NPC1 | O15118 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
| ▸ | SLC13A5 | Q86YT5 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL461258 | 0.78 | — | — | |
| Hydrochloric Acid SCHEMBL1359153 | 0.76 | — | — | |
| SCHEMBL28960760 | 0.76 | — | — | |
| SCHEMBL27319400 | 0.66 | GAA (0.43) | ALDH1A1KMT2ASMN1; SMN2MAPT | |
| SCHEMBL10722393 | 0.66 | — | — | |
| SCHEMBL23400943 | 0.65 | — | — | |
| SCHEMBL21576738 | 0.63 | MAPK1 (0.40) | ALDH1A1MAPK1MEN1KMT2ASMN1; SMN2 | |
| SCHEMBL13212232 | 0.62 | SLC9A1 (0.41) | ALDH1A1MAPK1MEN1KMT2ASMN1; SMN2 | |
| SCHEMBL12293938 | 0.62 | — | — | |
| SCHEMBL11499176 | 0.61 | SLC9A1 (0.42) | ALDH1A1MAPK1RAB9ANPC1HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1320527-B1 | METHOD FOR PRODUCING 1 SUBSTITUTED 5-CHLORO-4 METHYL PYRAZOLES | BASF SE (DE) | 2008-08-13 | — | — | EP | disclosed |
| US-7002023-B2 | Method for producing 1 substituted 5-chloro-4 methly pyrazoles | BASF AKTIENGESELLSCHAFT (DE) | 2006-02-21 | — | — | US | disclosed |
| US-20040102505-A1 | Method for producing 1 substituted 5-chloro-4 methly pyrazoles | BASF AKTIENGESELLSCHAFT (DE) | 2004-05-27 | — | — | US | disclosed |
| US-6515139-B1 | A process for preparing N-substituted 2-pyrazolin-5-ones of the formula I h R is C1-C8-alkyl, C5-C8-cycloalkyl, phenyl, naphthyl or phenyl- C1-C4-alkyl which may be unsubstituted or may carry one or more substituents which are inert towards | BASF AKTIENGESELLSCHAFT (DE) | 2003-02-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040102505-A1 | Method for producing 1 substituted 5-chloro-4 methly pyrazoles | CYP4F2, CYP2F1, CYP4F3 | ALDH1A1 245/4885MAPK1 2849/4885MEN1 241/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.